Dihydroorotate-Dehydrogenase-Inhibitors-Modulators-MCE_第1页
Dihydroorotate-Dehydrogenase-Inhibitors-Modulators-MCE_第2页
Dihydroorotate-Dehydrogenase-Inhibitors-Modulators-MCE_第3页
Dihydroorotate-Dehydrogenase-Inhibitors-Modulators-MCE_第4页
Dihydroorotate-Dehydrogenase-Inhibitors-Modulators-MCE_第5页
已阅读5页,还剩1页未读 继续免费阅读

Dihydroorotate-Dehydrogenase-Inhibitors-Modulators-MCE.docx 免费下载

版权说明:本文档由用户提供并上传,收益归属内容提供方,若内容存在侵权,请进行举报或认领

文档简介

1、 HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html Dihydroorotate HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html DehydrogenaseDHODHDihydroorotate dehydrogenase (DHODH) is the fourth

2、 enzyme in the de novo pyrimidine biosynthesis pathway, serving as thecatalyst to oxidize the dihydroorotate to orotic acid in the biosynthesis of uridine monophosphate (UMP). DHODH is a knowntarget for autoimmune diseases as well as an important target for malaria.Based on localization and electron

3、 acceptor, DHODHs have classified into two families: Family 1 members are soluble proteinslocalized to the cytosol, while family 2 members are membrane proteins localized to the inner mitochondrial membrane. Family 1 isfurther subdivided into family 1A and family 1B, which use fumarate and NAD+ (res

4、pectively) as electron acceptors. Family 2DHODH enzymes use respiratory quinones as electron acceptors.www.MedChemE 1 HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html Dihydroorotate HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html HYPERLINK https:/www.Me

5、dChemE/Targets/dihydroorotate-dehydrogenase.html Dehydrogenase HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html HYPERLINK https:/www.MedChemE/Targets/dihydroorotate-dehydrogenase.html Inhibitors HYPERLINK https:/www.MedChemE/e-z-ginkgolic-acid-c17-2.html (E/Z)-Ginkgolic HYPERL

6、INK https:/www.MedChemE/e-z-ginkgolic-acid-c17-2.html HYPERLINK https:/www.MedChemE/e-z-ginkgolic-acid-c17-2.html acid HYPERLINK https:/www.MedChemE/e-z-ginkgolic-acid-c17-2.html HYPERLINK https:/www.MedChemE/e-z-ginkgolic-acid-c17-2.html C17:2 HYPERLINK https:/www.MedChemE/e-z-ginkgolic-acid-c17-2.

7、html HYPERLINK https:/www.MedChemE/ag-636.html AG-636Cat. No.: HY-N7961 Cat. No.: HY-137463(E/Z)-Ginkgolic acid C17:2, isolated from Ginkgobiloba, can bind with human dihydroorotatedehydrogenase (DHODH) tightly.AG-636 is a potent, reversible, selective andorally active dihydroorotate dehydrogenase (

8、DHODH)inhibitor with an IC of 17 nM. AG-636 has strong50anticancer effects.Purity: 98%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgPurity: 98.02%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/ascochlorin-a.html

9、 Ascochlorin HYPERLINK https:/www.MedChemE/ascochlorin-a.html HYPERLINK https:/www.MedChemE/ascochlorin-a.html A(Acremochlorin A) Cat. No.: HY-139632 HYPERLINK https:/www.MedChemE/BAY-2402234.html BAY-2402234Cat. No.: HY-112645Ascochlorin A is a novel and potent hDHODHinhibitor (K = 3.29 M) for trea

10、tment ofDtriple-negative breast cancer.BAY-2402234 is a selective dihydroorotatedehydrogenase (DHODH) inhibitor for the treatmentof myeloid malignancies.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.95%Clinical Data: Phase 1Size: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 1

11、00 mg HYPERLINK https:/www.MedChemE/brd9185.html BRD9185Cat. No.: HY-120924 HYPERLINK https:/www.MedChemE/Brequinar.html Brequinar(DUP785; NSC 368390) Cat. No.: HY-108325BRD9185 is a Dihydroorotate dehydrogenase (DHODH)inhibitor, with an EC of 16 nM against50multidrug-resistant blood-stage parasites

12、 in vitroand is curative after just three doses in a P.berghei mouse model.Brequinar (DUP785) is a potent inhibitor ofdihydroorotate dehydrogenase (DHODH) with an ICof 5.2 nM for human DHODH. Brequinar haspotent activities against a broad spectrum ofviruses. Brequinar also has an anti-SARS2 activity

13、.50Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.75%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10 mg HYPERLINK https:/www.MedChemE/chikv-in-2.html CHIKV-IN-2 HYPERLINK https:/www.MedChemE/chikv-in-2.html HYPERLINK https:/www.MedChemE/dhodh-in-1.html DHODH-IN-1Cat. No

14、.: HY-132174 Cat. No.: HY-135282CHIKV-IN-2 is a potent inhibitor againstChikungunya virus (CHIKV), with excellent cellularantiviral activity (EC =270 nM) and improved90liver microsomal stability.DHODH-IN-1 (compound 18d) is a potentDihydroorotate Dehydrogenase (DHODH) inhibitorwith an IC of 25 nM. D

15、HODH-IN-1 is an inhibitor50of pyrimidine biosynthesis pathway.Purity: 98.15%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dhodh-in-11.html DHODH-IN-11 HYPERLINK

16、https:/www.MedChemE/dhodh-in-11.html HYPERLINK https:/www.MedChemE/dhodh-in-12.html DHODH-IN-12Cat. No.: HY-135675 Cat. No.: HY-135676DHODH-IN-11 (Compound 14b) is a Leflunomidederivative and a weak dihydroorotate dehydrogenase(DHODH) inhibitor with a pK of 5.03.aDHODH-IN-12 (Compound 12b) is a Lefl

17、unomidederivative and a weak dihydroorotate dehydrogenase(DHODH) inhibitor with a pK of 5.07.aPurity: 99.94%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg2 Tel: 609-228-6898 Fax: 609-228-5909 Email: sales

18、MedChemE HYPERLINK https:/www.MedChemE/dhodh-in-13.html DHODH-IN-13 HYPERLINK https:/www.MedChemE/dhodh-in-13.html HYPERLINK https:/www.MedChemE/dhodh-in-14.html DHODH-IN-14Cat. No.: HY-135677 Cat. No.: HY-135678DHODH-IN-13 (Compound 7a) is a hydroxyfurazananalog of A771726. DHODH-IN-13 is a dihydro

19、orotatedehydrogenase (DHODH) inhibitor with an IC of504.3 M for rat liver DHODH. DHODH-IN-13 can beused for rheumatoid arthritis.DHODH-IN-14 (Compound 7l) is a hydroxyfurazananalog of A771726. DHODH-IN-14 is a dihydroorotatedehydrogenase (DHODH) inhibitor with an IC of500.49 M for rat liver DHODH. D

20、HODH-IN-14 can beused for rheumatoid arthritis.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dhodh-in-15.html DHODH-IN-15 HYPERLINK https:/www.MedChemE/dhodh-in-15.html HYPERLINK https:

21、/www.MedChemE/dhodh-in-16.html DHODH-IN-16Cat. No.: HY-135679 Cat. No.: HY-139189DHODH-IN-15 (Compound 7b) is a hydroxyfurazananalog of A771726. DHODH-IN-15 is a dihydroorotatedehydrogenase (DHODH) inhibitor with an IC of5011 M for rat liver DHODH. DHODH-IN-15 can beused for rheumatoid arthritis.DHO

22、DH-IN-16 is a potent dihydroorotatedehydrogenase (DHODH) inhibitor with an IC of500.396 nM for human DHODH.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.88%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/dhodh-

23、in-17.html DHODH-IN-17 HYPERLINK https:/www.MedChemE/dhodh-in-17.html HYPERLINK https:/www.MedChemE/dhodh-in-18.html DHODH-IN-18Cat. No.: HY-128068 Cat. No.: HY-139889DHODH-IN-17, a 2-anilino nicotinic acid, is ahuman DHODH inhibitor (IC =0.40 M). DHODH-IN-1750can be used for theresearch of acute my

24、eloidleukemia (AML).DHODH-IN-18 is a human DHODH inhibitor (IC =500.2 nM).Purity: 99.91%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dhodh-in-19.html DHODH-IN-19 HYPERLINK https:/www.MedC

25、hemE/dhodh-in-19.html HYPERLINK https:/www.MedChemE/dhodh-in-20.html DHODH-IN-20Cat. No.: HY-144169 Cat. No.: HY-144371DHODH-IN-19 is a potent inhibitor of DHODH. DHODHis present in the inner membrane of humanmitochondria and is an iron-containingflavin-dependent enzyme. DHODH-IN-19 inhibitstumor gr

26、owth.DHODH-IN-20 (Compound 133) is a potent inhibitorof DHODH. DHODH is present in the inner membraneof human mitochondria and is an iron-containingflavin-dependent enzyme. DHODH-IN-20 inhibitstumor growth. DHODH-IN-20 has the potential forthe research of acute myelogenous leukemia.Purity: 98%Clinic

27、al Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dhodh-in-3.html DHODH-IN-3 HYPERLINK https:/www.MedChemE/dhodh-in-3.html HYPERLINK https:/www.MedChemE/dhodh-in-4.html DHODH-IN-4Cat. No.: HY-135618 Cat. No

28、.: HY-135619DHODH-IN-3 (compound 3) is a potent inhibitor ofHuman DihydroorotateDehydrogenases (HsDHODH) with an IC value50of 261 nM. DHODH-IN-3 binds to the the ubiquinonebinding cavities in DHODH with a Kapp of 32 nM.iDHODH-IN-4 (compound 17) is a human andPlasmodium falciparum dihydroorotatedehyd

29、rogenase (DHODH) inhibitor, with IC values50of 4 M and 0.18 M for PfDHODH and HsDHODH,respectively. DHODH-IN-4 (compound 17) possessantimalarial activity.Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 3 H

30、YPERLINK https:/www.MedChemE/dhodh-in-8.html DHODH-IN-8 HYPERLINK https:/www.MedChemE/dhodh-in-8.html HYPERLINK https:/www.MedChemE/DSM265.html DSM265Cat. No.: HY-135666 Cat. No.: HY-100184DHODH-IN-8 (Compound 27) is an inhibitor ofhuman and Plasmodium falciparumdihydroorotate dehydrogenase (DHODH)

31、with IC s50of 0.13 M and 47.4 M, and Ks of 0.016 M andi5.6 M, respectively. DHODH-IN-8 has antimalarialactivity.DSM265 is a long-duration inhibitor of P.falciparum dihydroorotate dehydrogenase(PfDHODH) with an IC of 8.9 nM. DSM265 can also50inhibit the growth of Pf3D7 parasites with anEC of 4.3 nM.5

32、0Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.72%Clinical Data: Phase 2Size: 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 250 mg, 500 mg HYPERLINK https:/www.MedChemE/dsm502.html DSM502 HYPERLINK https:/www.MedChemE/dsm502.html HYPERLINK https:/www.MedChemE/dsm705.html DSM705Cat

33、. No.: HY-132170 Cat. No.: HY-132171DSM502 is a pyrrole-based DihydroorotateDehydrogenase (DHODH) inhibitor. DSM502 exhibitsnanomolar potency againsts Plasmodium DHODH andPlasmodium parasites, with no inhibition ofmammalian DHODHs.DSM705 is a pyrrole-based DihydroorotateDehydrogenase (DHODH) inhibit

34、or. DSM705 exhibitsnanomolar potency against Plasmodium DHODH andPlasmodium parasites, with no inhibition ofmammalian DHODHs. DSM705 is a potent antimalarialcompound.Purity: 99.57%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 98%Clinical Data: No Developme

35、nt ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/dsm705-hydrochloride.html DSM705 HYPERLINK https:/www.MedChemE/dsm705-hydrochloride.html HYPERLINK https:/www.MedChemE/dsm705-hydrochloride.html hydrochlorideCat. No.: HY-132171A HYPERLINK https:/www.MedChemE/aslan003.html Farudodstat(ASLAN00

36、3) Cat. No.: HY-129239DSM705 hydrochloride, an orally activeantimalarial compound, is a pyrrole-basedDihydroorotate Dehydrogenase (DHODH)inhibitor.Farudodstat (ASLAN003) is an orally active andpotent Dihydroorotate Dehydrogenase (DHODH)inhibitor with an IC of 35 nM for human DHODH50enzyme. Farudodst

37、at inhibits protein synthesis viaactivation of AP-1 transcription factors.Purity: 99.56%Clinical Data: No Development ReportedSize: 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.95%Clinical Data: Phase 2Size: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/dhodh-in-2.html h

38、DHODH-IN-3 HYPERLINK https:/www.MedChemE/dhodh-in-2.html HYPERLINK https:/www.MedChemE/dhodh-in-5.html hDHODH-IN-4Cat. No.: HY-135570 Cat. No.: HY-128787hDHODH-IN-3 (compound 21d) is a humandihydroorotate dehydrogenase (HsDHODH)inhibits measles virus replication with apMIC value of 8.6.50inhibitor,h

39、DHODH-IN-4 is a potent human dihydroorotatedehydrogenase (DHODH) inhibitor, with a pIC of507.8 for human recombinant DHODH. hDHODH-IN-4inhibits measles virus replication, with apMIC of 8.8.50Purity: 99.86%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity: 99.75

40、%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg HYPERLINK https:/www.MedChemE/dhodh-in-7.html hDHODH-IN-5 HYPERLINK https:/www.MedChemE/dhodh-in-7.html HYPERLINK https:/www.MedChemE/dhodh-in-9.html hDHODH-IN-7Cat. No.: HY-135664 Cat. No.: HY-135667DHODH-IN-7 is a human di

41、hydroorotate dehydrogenase(DHODH) inhibitor, with an IC of 0.91 M.50DHODH-IN-7 induces differentiation in acutemyeloid leukemia.DHODH-IN-9 (Compound 10k) is an azine-bearinganalogue and is a human dihydroorotatedehydrogenase inhibitor. DHODH-IN-9 has antiviraleffect with a pMIC of 7.4.50Purity: 98%C

42、linical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg4 Tel: 609-228-6898 Fax: 609-228-5909 Email: salesMedChemE HYPERLINK https:/www.MedChemE/indoluidin-e.html Indoluidin HYPERLINK https:/www.MedChemE/indoluidin-e.html HYPERLINK https:

43、/www.MedChemE/indoluidin-e.html ECat. No.: HY-139825 HYPERLINK https:/www.MedChemE/laflunimus.html Laflunimus(HR325) Cat. No.: HY-101813Indoluidin E selectively inhibits DHODH andsuppresses cancer cell growth.Laflunimus (HR325) is an immunosuppressive agentand an analogue of the Leflunomide-activeme

44、tabolite A77 1726. Laflunimus is an orallyactive inhibitor of dihydroorotate dehydrogenase(DHODH).Purity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 99.26%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mg HYPERLINK https:/www.MedChemE/leflunomid

45、e.html Leflunomide(HWA486; RS-34821; SU101) Cat. No.: HY-B0083 HYPERLINK https:/www.MedChemE/leflunomide-d4.html Leflunomide-d4Cat. No.: HY-B0083SLeflunomide is a pyrimidine synthesis inhibitor,inhibiting dihydroorotate dehydrogenase (DHODH),and acts as a disease-modifying antirheumaticdrug.Leflunom

46、ide-d4 (HWA486-d4) is the deuteriumlabeled Leflunomide. Leflunomide is a pyrimidinesynthesis inhibitor, inhibiting dihydroorotatedehydrogenase (DHODH), and acts as adisease-modifying antirheumatic drug.Purity: 99.72%Clinical Data: LaunchedSize: 10 mM 1 mL, 100 mg, 500 mgPurity: 98%Clinical Data:Size

47、: 1 mg, 10 mg HYPERLINK https:/www.MedChemE/ML390.html ML390 HYPERLINK https:/www.MedChemE/ML390.html HYPERLINK https:/www.MedChemE/p1788.html P1788Cat. No.: HY-100688 Cat. No.: HY-146317ML390 is a potent dihydroorotate dehydrogenase(DHODH) inhibitor. ML390 is an inducer of myeloiddifferentiation an

48、d causes myeloid differentiationin murine (ER-HoxA9) and human (U937 and THP1)acute myeloid leukemia (AML) models.P1788 is a dihydroorotate dehydrogenase (DHODH)inhibitor. P1788 induces DNA damage.Purity: 98.77%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 50 mg, 100 mgPurity:

49、 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mg HYPERLINK https:/www.MedChemE/pfdhodh-in-2.html PfDHODH-IN-2 HYPERLINK https:/www.MedChemE/pfdhodh-in-2.html HYPERLINK https:/www.MedChemE/ptc299.html PTC299Cat. No.: HY-W078844 Cat. No.: HY-124593PfDHODH-IN-2, a dihydrothiophenone derivativ

50、e(Compound 11), is a potent Plasmodiumfalciparum dihydroorotate dehydrogenase(PfDHODH) inhibitor with an IC of 1.11 M.50PfDHODH-IN-2 acts as an antimalarial agent and canbe used for the research of malaria.PTC299 is an orally active inhibitor of VEGFAmRNA translation that selectively inhibits VEGFpr

51、otein synthesis at the post-transcriptionallevel. PTC299 is also a potent inhibitor ofdihydroorotate dehydrogenase (DHODH).Purity: 99.83%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg, 10 mg, 25 mg, 50 mg, 100 mgPurity: 99.52%Clinical Data: No Development ReportedSize: 10 mM 1 mL, 5 mg

52、, 10 mg, 25 mg, 50 mg HYPERLINK https:/www.MedChemE/rort-dhodh-in-1.html RORt/DHODH-IN-1 HYPERLINK https:/www.MedChemE/rort-dhodh-in-1.html HYPERLINK https:/www.MedChemE/rort-dhodh-in-2.html RORt/DHODH-IN-2Cat. No.: HY-142843 Cat. No.: HY-142834RORt/DHODH-IN-1 (compound (R)-14d) is a potentand orall

53、y active dual RORt/DHODH inhibitor,with IC s of 0.083 M and 0.172 M, respectively.50RORt/DHODH-IN-1 exhibits remarkable in vivoanti-inflammatory activity.RORt/DHODH-IN-2 (compound 1) is a potent dualRORt/DHODH inhibitor. RORt/DHODH-IN-2 can beused for inflammatory bowel disease (IBD)research.Purity:

54、 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgPurity: 98%Clinical Data: No Development ReportedSize: 1 mg, 5 mgwww.MedChemE 5 HYPERLINK https:/www.MedChemE/rort-dhodh-in-3.html RORt/DHODH-IN-3 HYPERLINK https:/www.MedChemE/rort-dhodh-in-3.html HYPERLINK https:/www.MedChemE/Tenovin-1.html Tenovin-1Cat. No.: HY-142847 Cat. No.: HY-13423RORt/DHODH-IN-3 (compound (S)-14d) is a dual

温馨提示

  • 1. 本站所有资源如无特殊说明,都需要本地电脑安装OFFICE2007和PDF阅读器。图纸软件为CAD,CAXA,PROE,UG,SolidWorks等.压缩文件请下载最新的WinRAR软件解压。
  • 2. 本站的文档不包含任何第三方提供的附件图纸等,如果需要附件,请联系上传者。文件的所有权益归上传用户所有。
  • 3. 本站RAR压缩包中若带图纸,网页内容里面会有图纸预览,若没有图纸预览就没有图纸。
  • 4. 未经权益所有人同意不得将文件中的内容挪作商业或盈利用途。
  • 5. 人人文库网仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对用户上传分享的文档内容本身不做任何修改或编辑,并不能对任何下载内容负责。
  • 6. 下载文件中如有侵权或不适当内容,请与我们联系,我们立即纠正。
  • 7. 本站不保证下载资源的准确性、安全性和完整性, 同时也不承担用户因使用这些下载资源对自己和他人造成任何形式的伤害或损失。

评论

0/150

提交评论